机构:[1]Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi, 530021, China; Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China.四川省人民医院[2]School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610047, China.四川省人民医院[3]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610047, China.四川省人民医院[4]Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610047, China. Electronic address: wuhongzao@126.com.四川省人民医院[5]Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi, 530021, China; Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610047, China. Electronic address: xuchuan100@163.com.四川省人民医院
第一作者机构:[1]Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning, Guangxi, 530021, China; Department of Oncology & Cancer Institute, Sichuan Academy of Medical Sciences, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China; Department of Laboratory Medicine and Sichuan Provincial Key Laboratory for Human Disease Gene Study, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, Sichuan, 610072, China.
推荐引用方式(GB/T 7714):
Li Feifei,Peng Xinhao,Zheng Linlin,et al.Corrigendum to "YAP nuclear translocation facilitates radiation resistance in nasopharyngeal carcinoma cells" [BBRC 670 (2023) 109-116[J].Biochemical and biophysical research communications.2023,678:207-208.doi:10.1016/j.bbrc.2023.09.001.
APA:
Li Feifei,Peng Xinhao,Zheng Linlin,Liu Yiqiang,Liu Qianshi...&Xu Chuan.(2023).Corrigendum to "YAP nuclear translocation facilitates radiation resistance in nasopharyngeal carcinoma cells" [BBRC 670 (2023) 109-116.Biochemical and biophysical research communications,678,
MLA:
Li Feifei,et al."Corrigendum to "YAP nuclear translocation facilitates radiation resistance in nasopharyngeal carcinoma cells" [BBRC 670 (2023) 109-116".Biochemical and biophysical research communications 678.(2023):207-208